Skip to main navigation Skip to search Skip to main content

Analysis of somatic microsatellite indels identifies driver events in human tumors

  • Yosef E. Maruvka
  • , Kent W. Mouw
  • , Rosa Karlic
  • , Prasanna Parasuraman
  • , Atanas Kamburov
  • , Paz Polak
  • , Nicholas J. Haradhvala
  • , Julian M. Hess
  • , Esther Rheinbay
  • , Yehuda Brody
  • , Amnon Koren
  • , Lior Z. Braunstein
  • , Alan D'Andrea
  • , Michael S. Lawrence
  • , Adam Bass
  • , Andre Bernards
  • , Franziska Michor
  • , Gad Getz

Research output: Contribution to journalArticlepeer-review

109 Scopus citations

Abstract

Microsatellites (MSs) are tracts of variable-length repeats of short DNA motifs that exhibit high rates of mutation in the form of insertions or deletions (indels) of the repeated motif. Despite their prevalence, the contribution of somatic MS indels to cancer has been largely unexplored, owing to difficulties in detecting them in short-read sequencing data. Here we present two tools: MSMuTect, for accurate detection of somatic MS indels, and MSMutSig, for identification of genes containing MS indels at a higher frequency than expected by chance. Applying MSMuTect to whole-exome data from 6,747 human tumors representing 20 tumor types, we identified >1,000 previously undescribed MS indels in cancer genes. Additionally, we demonstrate that the number and pattern of MS indels can accurately distinguish microsatellite-stable tumors from tumors with microsatellite instability, thus potentially improving classification of clinically relevant subgroups. Finally, we identified seven MS indel driver hotspots: Four in known cancer genes (ACVR2A, RNF43, JAK1, and MSH3) and three in genes not previously implicated as cancer drivers (ESRP1, PRDM2, and DOCK3).

Original languageEnglish
Pages (from-to)951-959
Number of pages9
JournalNature Biotechnology
Volume35
Issue number10
DOIs
StatePublished - 1 Oct 2017
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2017 Nature America, Inc.

Funding

We thank C. Mayer for supplying and supporting the PHOBOS tool. G.G. was partially funded by the Paul C. Zamecnick, MD, Chair in Oncology at MGH and the NIH TCGA Genome Data Analysis Center (NIH U24CA143845). Y.E.M., P. Polak, and A. Kamburov were funded by G.G.’s start-up funds at Massachusetts General Hospital. K.W.M. was partially funded by an American Society of Radiation Oncology (ASTRO) Junior Faculty Career Research Training Award and a Harvard Catalyst KL2/CMeRIT Award. F.M. gratefully acknowledges support from the Dana-Farber Cancer Institute Physical Sciences Oncology Center (NIH U54CA193461). R.K. was supported by the European Commission Seventh Framework Programme (Integra-Life; grant 315997) and the Croatian Science Foundation (grant IP-2014-09-6400).

FundersFunder number
Dana-Farber Cancer Institute Physical Sciences Oncology CenterU54CA193461
National Institutes of HealthU24CA143845
National Cancer InstituteK08CA219504
American Society for Radiation Oncology
Massachusetts General Hospital
Hrvatska Zaklada za ZnanostIP-2014-09-6400
Seventh Framework Programme315997

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Fingerprint

    Dive into the research topics of 'Analysis of somatic microsatellite indels identifies driver events in human tumors'. Together they form a unique fingerprint.

    Cite this